Levation Pharma
Tel Aviv · Founded 2017
About Levation Pharma
Levation Pharma develops LEV-102, a topical gel using oxymetazoline to lift upper eyelids and improve visual fields.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.1M
- Last round: Series Unknown (Jun 2022)
- Website: https://levationpharma.com/
Industries & Categories
Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/levation-pharma-198272 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.